. 2016 Jun 20;11(6):e0157039. doi: 10.1371/journal.pone.0157039

Table 1. Lopinavir (200 mg)/Ritonavir (50 mg) drug sources and characteristics.

Site	Lot No.	Manufacturer	Country	Trade name	WHO Prequal.	Expiry date	Identification	% of label amount	Uniformity of mass, %		Dissolution, % (LPV/RTV)
Site	Lot No.	Manufacturer	Country	Trade name	WHO Prequal.	Expiry date	Identification	% of label amount	Min	Max	Min	Max
001	W570041	GPO	THA	Lopinavir/Ritonavir	NO	21 Jan 16	Positive	102.1/100.8	-1.20	1.64	97.6/98.8	98.2/99.7
002	W560404	GPO	THA	Lopinavir/Ritonavir	NO	13 Jul 15	Positive	103.2/102.4	-1.28	1.48	98.1/100.8	99.1/102.2
003	W570169	GPO	THA	Lopinavir/Ritonavir	NO	17 Mar 16	Positive	102.1/103.6	-1.11	1.25	99.1/100.0	101.2/103.1
004	W570175	GPO	THA	Lopinavir/Ritonavir	NO	17 Mar 16	Positive	101.0/103.3	-2.22	2.08	97.7/99.0	101.9/102.5
005	W570450	GPO	THA	Lopinavir/Ritonavir	NO	17 Jul 16	Positive	99.4/101.8	-2.16	1.07	97.5/99.0	101.3/102.8
006	W560432	GPO	THA	Lopinavir/Ritonavir	NO	23 Jul 15	Positive	99.0/103.0	-2.10	1.87	98.5/100.3	102.6/104.6
007	W570457	GPO	THA	Lopinavir/Ritonavir	NO	20 Jul 16	Positive	98.6/101.5	-1.74	2.05	98.7/95.0	99.8/97.0
008	W570152	GPO	THA	Lopinavir/Ritonavir	NO	10 Mar 16	Positive	99.4/101.4	-2.09	1.76	96.2/99.0	98.7/102.8
009	W570285	GPO	THA	Lopinavir/Ritonavir	NO	15 May 16	Positive	98.4/101.0	-2.53	1.94	96.8/99.9	99.8/102.7
010	W560556	GPO	THA	Lopinavir/Ritonavir	NO	22 Oct 15	Positive	97.8/101.5	-1.47	1.70	99.1/101.4	101.7/103.7
011	W570169	GPO	THA	Lopinavir/Ritonavir	NO	17 Mar 16	Positive	98.2/101.2	-1.33	1.52	94.9/100.0	97.6/102.8
012	8000458	Mylan	IND	Lopinavir/Ritonavir	YES	30 Jun 16	Positive	99.7/101.4	-1.69	1.31	93.4/96.3	98.6/102.9

Abbreviations: Lopinavir,LPV; Ritonavir, RTV; the Government Pharmaceutical Organization, GPO; Thailand, THA; India, IND.